S AUSIM AZIZI
Medical Practice in Philadelphia, PA
License number
Pennsylvania MD053664L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Philadelphia, PA 19140
Professional information
Dr. S Ausim Azizi, Philadelphia PA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
Temple University Hospital
3401 N Broad St, Philadelphia 19140
(800) 836-7536 (Phone)
3401 N Broad St, Philadelphia 19140
(800) 836-7536 (Phone)
Procedures:
Brain Tumors, Movement Disorders, Multiple Sclerosis, Pain Management, Repair and Regeneration Of Damaged Nervous Systems, Stroke
Conditions:
Brain Tumors, Movement Disorders, Multiple Sclerosis (Ms), Nervous System Disorders, Neurological Disorders, Pain Management, Stroke
Certifications:
Neurology, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Temple University Hospital
3401 N Broad St, Philadelphia 19140
Temple University Hospital
3401 North Broad St, Philadelphia 19140
3401 N Broad St, Philadelphia 19140
Temple University Hospital
3401 North Broad St, Philadelphia 19140
Education:
Medical School
University Of Texas Southwestern Medical Center At Dallas
Graduated: 1990
Yale New Haven Hospital
Graduated: 1991
Graduated: 1994
University Of Texas Southwestern Medical Center At Dallas
Graduated: 1990
Yale New Haven Hospital
Graduated: 1991
Graduated: 1994
Isolated Stromal Cells For Use In The Treatment Of Diseases Of The Central Nervous System
US Patent:
2003003, Feb 27, 2003
Filed:
Feb 24, 1998
Appl. No.:
09/028395
Inventors:
DARWIN J. PROCKOP - PHILADELPHIA PA, US
DAVID G STOKES - WILLOW GROVE PA, US
S AUSIM AZIZI - PHILADELPHIA PA, US
DAVID G STOKES - WILLOW GROVE PA, US
S AUSIM AZIZI - PHILADELPHIA PA, US
International Classification:
A61K048/00, C12N005/08
US Classification:
424/093210, 435/368000
Abstract:
Methods of treating a human patient having a disease, disorder or condition of the central nervous system are disclosed. The methods include obtaining a bone marrow sample from a human donor, isolating stromal cells from the bone marrow sample, and administering the isolated stromal cells to the central nervous system of the human patient, wherein the presence of the isolated stromal cells in the brain effects treatment of the disease, disorder or condition. Stromal cells which are isolated may be cultured in vitro, they may be genetically engineered to produce therapeutic compounds, and/or they may be pre-differentiated prior to administration into the central nervous system.